Herzliya Medical Center
Tel: +972-9-959-4888
09:00-18:00
Leading oncologists at Herzliya Medical Center carry out treatment of testicular cancer in Israel. Treatment by HMC staff in Israel uses the most modern methods. Israeli oncologists have been incredibly successful in the treatment of testicular cancer, supported by sophisticated methods of diagnosis and surgical techniques.
Testicular cancer involves two types of malignant tumors, originating from membranes and parenchyma:
Both of the types of malignancies mentioned have subtypes. Testicular tumors, depending on their histological structure, significantly differ in growth rate and tendency to metastasize. Seminomas tend to have a slower growth rate than non-seminomas. The most aggressive forms of testicular cancer are non-seminomas, subtype embryonal carcinoma, and choriocarcinoma. Typically, testicular cancer develops after puberty. Most cases are found in patients aged 15 to 55 years.
Testicular cancer research has identified a number of factors that increase the likelihood of cancer development, including:
The first symptom of testicular cancer usually presents as a painless increase in the size of one of the testicles, eventually causing discomfort. Pain occurs as tumor growth ensues, stretching the capsule of the testis. Difficulty in venous outflow leading to swelling of the scrotum is observed in the early stages. In advanced stages, symptoms include increased size of regional (inguinal) lymph nodes and signs of metastatic lesions on internal organs. Any increase in the size of the testes as well as the presence of blood in the semen are possible sings of tumor existence and require immediate clinical treatment.
Specialists at HMC in Israel use the following diagnostic tools specific to testicular cancer:
Oncologists at HMC in Israel select the type of testicular cancer treatment according to histological classification and stage of tumor spread. The main methods of testicular cancer treatment in Israel are:
The main methods of evaluating the effectiveness of the treatment of testicular cancer are further control determination of the level of tumor markers and locating sites of pathological uptake of the radioactive isotopes by way of a PET-CT scan.
Well received treatments for testicular cancer using modern methods of anti-cancer therapies, allow doctors at HMC in Israel to achieve a high percentage (95%) of complete recovery even in cases of advanced metastases. The ability to make an accurate diagnosis of testicular cancer, as well as a highly professional approach to the treatment of this type of cancer, yield excellent results. Oncologists at Herzliya Medical Center in Israel develop an individual treatment program for each patient, using the most effective systems available. Follow-up throughout treatment and thereafter is necessary to prevent relapse of the disease and allows time to target any appearance of secondary cancer.